Navigation Links
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
Date:2/6/2009

CAMBRIDGE, Mass. and LONDON, Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) and GlaxoSmithKline (GSK) today announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899. IDX899 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) in Phase II clinical development being developed by Idenix for the treatment of HIV/AIDS. New NNRTIs are needed to address the increasing prevalence of viral resistance and side effects associated with this drug class. To date, IDX899 has demonstrated high potency with low milligram doses, a high barrier to drug resistance, favorable risk/benefit profile, and the convenience of once-a-day administration.

Under the terms of the agreement, GSK will assume all development responsibility and associated costs for IDX899, and Idenix will receive an upfront payment of $34 million and will be eligible to receive up to $416 million in development, regulatory and sales milestones. Furthermore, if IDX899 is successfully developed and commercialized, Idenix will receive double-digit, tiered worldwide royalties.

"GSK, with a well-established HIV franchise and substantial drug development experience, is the ideal collaborator to help maximize the potential of IDX899," said Jean-Pierre Sommadossi, Chief Executive Officer of Idenix. "For Idenix, the significant value created through the license of IDX899 enables us to focus all of our resources on advancing our core strategic HCV assets, which include drug candidates from the three major classes of direct-acting HCV antivirals."

"IDX899 may play a significant role in improving treatment options for people with HIV/AIDS," commented Zhi Hong, Senior Vice President of the Infectious Diseases Centre of Excellence for Drug Discovery (ID CEDD) at GSK. "A once-daily, lower-dose
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
2. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
3. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
4. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
5. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
7. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
8. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
9. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
10. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
11. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... the Netherlands , May 5, 2015 ... lower esophageal sphincter (LES) stimulation therapy for gastroesophageal ... and efficacy results. The results demonstrated an excellent ... regurgitation and the "gold-standard" esophageal acid exposure (measured ... of dependence on daily PPI medications. ...
(Date:5/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/9pthtm/home_healthcare ) has ... Market - Forecast to 2020" report to their ... to reach more than $300+ billion growing at a ... equipment market is expected to grow at a faster ... is gaining a tremendous attention over hospitals for the ...
(Date:5/5/2015)... Calif., May 5, 2015 Isis Pharmaceuticals, Inc. ... income of $4.0 million for the three months ended ... operating loss of $22.6 million for the same period ... to higher revenue from milestone payments earned from its ... a GAAP basis, Isis reported a loss from operations ...
Breaking Medicine Technology:Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 13
(Date:5/6/2015)... TX (PRWEB) May 06, 2015 The ... opened its first freestanding emergency room in Chandler on ... Health Arizona General Hospital, which is also part of ... celebrate the grand opening, Dignity Health Arizona General Hospital ... Chandler Chamber of Commerce and donated $5,000 to Campo ...
(Date:5/6/2015)... London, England (PRWEB) May 06, 2015 ... exploding with new drinks. Little Miracles organic tea and ... by natural Panax ginseng and sweetened with agave, these ... popular consumer movement that seeks healthier ways to hydrate. ... 6, Little Miracles invites people to raise a bottle ...
(Date:5/5/2015)... (PRWEB) May 06, 2015 Social Media ... Make Social Media Your Most Powerful Marketing Tool and ... Washington, DC, http://www.fdanews.com/SocialMedia , Social media … ... of social media’s reach. Patients are using it — ... doctors about what they’ve discovered. , But, it can ...
(Date:5/5/2015)... May 05, 2015 With the FCPX LUT: ... quickly and easily add washed color grades to footage. A ... for modifying an image. The LUT changes every pixel's color ... comes with 90 washed CUBE LUT files. , This plugin ... can give any footage a washed look. , CUBE ...
(Date:5/5/2015)... UAE (PRWEB) May 05, 2015 Private ... , FZ LLC has announced that its dental stem ... for Store-A-Tooth™ increased once again--in April, 2015 –and posted ... month of increased record volume and represents a significant ... Provia’s dental stem cell biobank is conducted via the ...
Breaking Medicine News(10 mins):Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 3Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3
... Obama and Secretary of State Clinton on today,s nomination of ... Global AIDS Coordinator (OGAC). AIDS Action is pleased that ... by such an accomplished HIV medical expert with extensive knowledge ... the epidemic here in the United States. We encourage ...
... , Incorporated, a leading provider of business ... services, continues to expand its portfolio of innovative ... RACSource, a financial management and appeals analysis ... SOURCECORP ,s extensive experience in denial management, ...
... Indian Oncologists Are Starting to Embrace Use of ... a Report from Decision Resources WALTHAM, Mass., April ... leading research and advisory firms focusing on pharmaceutical ... brand/generics (oxaliplatin) and Roche/Chugai,s Xeloda, Indian brand/generics (capecitabine) ...
... WASHINGTON, April 28 First quarter federal reports ... provisions of the federal economic stimulus act, contradicting ... report of its effort was "100 percent false."Google,s ... lobbying during the period including on "online health-related ...
... Mich., April 28 Richard E. Smith, M.D., an ... as the 144th president of the Michigan State Medical ... MSMS House of Delegates meeting in Grand Rapids. (Logo: ... first African American to serve as MSMS president, will ...
... university Karolinska Institutet have shown that rapid diagnostic tests ... healthcare in low and mid-income countries in the fight ... a simple blood test and, according to the results, ... receive the right treatment at no extra cost for ...
Cached Medicine News:Health News:AIDS Action Applauds Selection of Dr. Eric Goosby as Global AIDS Coordinator 2Health News:SOURCECORP(R) HealthSERVE Unveils Unique Tool for Healthcare Providers to Support Recovery Audit Contractor (RAC) Program Defense 2Health News:Sanofi-Aventis' and Roche/Chugai's Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 3Health News:Richard E. Smith, M.D., Installed as President of Michigan State Medical Society 2Health News:Richard E. Smith, M.D., Installed as President of Michigan State Medical Society 3Health News:Simple blood test proves powerful ally in the fight against malaria 2
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: